Generate Biomedicines
IPO
- Headquarters
- Cambridge, Massachusetts
- Employees
- 201–500
- Founded
- 2018
- Business Model
- B2B
- Website
- generatebiomedicines.com
- Total Funding
- $693.0M
- Valuation
- $2.0BFeb 2026
- Last Round
- $273.0M Corporate RoundDec 2024
- Rounds
- 4
About
AI-powered generative biology platform creating novel protein therapeutics across antibodies, peptides, and enzymes.
Funding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account